Skip to main content
. 2012 Nov 17;380(9855):1741–1748. doi: 10.1016/S0140-6736(12)61422-6

Table 2.

Incidence of death by study group and hazard ratios for mortality in the ADDITION-Cambridge trial

No-screening control group
Screening group
Hazard ratio (95%CI)*
Number of deaths Person-years of follow-up Rate per 1000 person-years (95% CI) Number of deaths Person-years of follow up Rate per 1000 person-years (95% CI)
All-cause mortality 377 38 126 9·89 (8·94–10·94) 1532 145 930 10·50 (9·99–11·04) 1·06 (0·90–1·25)
Cardiovascular mortality 124 38 126 3·25 (2·73–3·88) 482 145 930 3·30 (3·02–3·61) 1·02 (0·75–1·38)
Cancer mortality 169 38 126 4·43 (3·81–5·15) 697 145 930 4·78 (4·43–5·14) 1·08 (0·90–1·30)
Other causes of death 84 38 126 2·20 (1·78–2·73) 353 145 930 2·42 (2·18–2·68) 1·10 (0·87–1·39)
*

Accounting for clustering.